TNFRSF9 and lung cancer: Furthermore, we aimed to test the hypothesis that equivocal ILA, ILA, and ILD have a progressively deleterious impact on all-cause mortality and acute exacerbation of interstitial pneumonia (AEIP) in patients with lung cancer.